Anemia hemolítica autoinmune desencadenada por SARS-CoV-2 Reporte de un caso / SARS-CoV-2-Induced Autoimmune Hemolytic Anemia: Case Report
Rev. Fac. Med. UNAM
;
65(1): 26-36, ene.-feb. 2022. tab, graf
Artigo
em Espanhol
|
LILACS-Express
| LILACS
| ID: biblio-1376288
RESUMEN
Resumen Infection by SARS-CoV-2 virus is not solely limited to the common clinical presentation of acute respiratory distress syndrome, mainly because a wide spectrum of clinical manifestation has been observed. These presentations include, but are not limited to, neurological, cardiovascular, throm- boembolic, hematologic, and autoimmune presentations. Within this wide spectrum, cases of autoimmune hemolytic anemia due to SARS-CoV-2 infection are rising. This is why primary care physicians should be ready to identify this clinical entity appropriately.
ABSTRACT
Abstract Infection by SARS-CoV-2 virus is not solely limited to the common clinical presentation of acute respiratory distress syndrome, mainly because a wide spectrum of clinical manifestation has been observed. These presentations include, but are not limited to, neurological, cardiovascular, throm- boembolic, hematologic, and autoimmune presentations. Within this wide spectrum, cases of autoimmune hemolytic anemia due to SARS-CoV-2 infection are rising. This is why primary care physicians should be ready to identify this clinical entity appropriately.
Texto completo:
DisponíveL
Índice:
LILACS (Américas)
Idioma:
Espanhol
Revista:
Rev. Fac. Med. UNAM
Assunto da revista:
Medicina
Ano de publicação:
2022
Tipo de documento:
Artigo
País de afiliação:
México
Instituição/País de afiliação:
Hospital Juárez de México/MX
/
Instituto Nacional de Cardiología Ignacio Chávez/MX
Similares
MEDLINE
...
LILACS
LIS